Anthony S. Fauci

Georgetown University — United States

Immunology and Microbiology · Life Sciences

184h-index135.9kcitations1.1kworks0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(347), Immune Cell Function and Interaction(268), T-cell and B-cell Immunology(173), HIV/AIDS Research and Interventions(155), HIV/AIDS drug development and treatment(91)

Publications1.1k total

Reflection on the Legacy of Lawrence Gostin in Global Health
The Journal of Law Medicine & Ethics·2025Open Access
HIV/AIDS and COVID-19: Shared Lessons From 2 Pandemics
Clinical Infectious Diseases·2024· 3 citedOpen Access
Immunology of AIDS and HIV Infection
2024
Expanded Access of Unproven Drugs: Not the Final Word
NEJM Evidence·2024
RNA vaccines: A transformational advance
Immunity·2023· 10 cited
What keeps me up at night
Science Translational Medicine·2023· 1 cited
Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis
The Lancet·2023· 72 cited
Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles
Proceedings of the National Academy of Sciences·2023· 13 citedOpen Access
Audio Interview: Dr. Fauci on Infectious Disease Challenges
New England Journal of Medicine·2023
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities—workshop report
npj Vaccines·2023· 100 citedOpen Access
Pandemic Preparedness and Response: Lessons From COVID-19
The Journal of Infectious Diseases·2023· 58 citedOpen Access
MAdCAM-1 costimulation in the presence of retinoic acid and TGF-β promotes HIV infection and differentiation of CD4+ T cells into CCR5+ TRM-like cells
PLoS Pathogens·2023· 12 citedOpen Access
The NIH-led research response to COVID-19
Science·2023· 45 cited
Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses
Cell Host & Microbe·2023· 175 citedOpen Access
Forty years of investment in HIV research: progress towards ending the HIV pandemic and preparation for future pandemics
Journal of the International AIDS Society·2022· 8 citedOpen Access
It Ain’t Over Till It’s Over…but It’s Never Over — Emerging and Reemerging Infectious Diseases
New England Journal of Medicine·2022· 48 cited
Anti-PF4 antibodies associated with disease severity in COVID-19
Proceedings of the National Academy of Sciences·2022· 26 citedOpen Access
Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report
Annals of the New York Academy of Sciences·2022· 11 citedOpen Access
Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
Cell·2022· 65 citedOpen Access
Legends of allergy and immunology: Lorenzo Moretta—Unfolding the mysteries of NK cells and much more
Allergy·2022
page 1 of 53Next →

Frequent Co-authors

Gene G. Hunder(7), D. Blöch(7), Beat A. Michel(7), Mary Betty Stevens(7), William P. Arend(7), Leonard H. Calabrese(7), Randi Y. Leavitt(7), J. T. Lie(7), Robert W. Lightfoot(7), Alfonse T. Masi(7), Dennis J. McShane(7), Joseph L. Mills(7), Stanley L. Wallace(7), Nathan J. Zvaifler(7), David M. Morens(6), H. Clifford Lane(6), Tae‐Wook Chun(5), Steven M. Edworthy(4), Jan M. Orenstein(4), Michael Baseler(3)